Nutrition & Diet Plans

The Real BMI and Waist Cutoffs for Indians: Not the Western Ones

Gayatri Kharde

Gayatri Kharde

Nutritionist, Voy India

The Real BMI and Waist Cutoffs for Indians: Not the Western Ones

If a global BMI chart calls you "normal" but an Indian doctor still frowns at your waistline, both can be right. For Asian Indians, the risk thresholds sit lower than the Western ones. Overweight begins at a BMI of 23 instead of 25. Obesity begins at 25 instead of 30. Abdominal obesity begins at a waist of 90 cm for men and 80 cm for women.

These are Indian consensus cutoffs built on Indian data. They exist because many Indians develop diabetes and heart disease at body sizes that international charts still label healthy.

Key Takeaways:

  • Indian medical consensus sets the overweight BMI threshold between 23 and 24.9.
  • Obesity is formally diagnosed at a BMI of 25 or above.
  • Waist limits are lower for Indians, set at 90 cm or more for men and 80 cm or more for women.
  • These adjusted metrics exist because South Asians tend to carry more visceral fat at lower body weights.
  • Proper tape placement just above the hip bone is critical for an accurate waist measurement.

What are the Indian BMI and waist cutoffs?

For Asian Indians, the metabolic risk cutoffs are a BMI of 23 to 24.9 kg/m² for overweight and 25 kg/m² or above for obesity. Abdominal obesity requires a waist circumference of 90 cm or more in men and 80 cm or more in women. Western charts place those same lines at 25 and 30 for BMI.

The Indian numbers move the threshold earlier because cardiometabolic risk in this population climbs at a lower body size.

Indian vs WHO BMI and Waist Cutoffs

Overweight

  • Indian consensus: BMI of 23.0 to 24.9 kg/m²
  • Standard WHO cutoff: BMI of 25.0 to 29.9 kg/m²

Obesity

  • Indian consensus: BMI of 25 kg/m² or above
  • Standard WHO cutoff: BMI of 30 kg/m² or above

Abdominal obesity in men

  • Indian consensus: Waist circumference of 90 cm or more
  • Standard WHO cutoff: Waist circumference of 94 cm or more

Abdominal obesity in women

  • Indian consensus: Waist circumference of 80 cm or more
  • Standard WHO cutoff: Waist circumference of 80 cm or more

Waist-to-height ratio

  • Indian consensus: Greater than 0.5
  • Standard WHO cutoff: Greater than 0.5

Keep your waist under half your height. A waist-to-height ratio above 0.5 is treated as a marker of abdominal risk for both sexes.

Why are the Indian numbers lower than the Western ones?

The lower cutoffs answer a real biological pattern rather than a rounding preference. Asian Indians tend to carry more body fat at any given BMI than white Europeans do. More of this fat is stored deep in the abdomen. That is the thin outside, fat inside phenotype. It means a person can look slim and sit inside the normal BMI band but still carry a metabolic risk profile closer to someone the chart would call overweight.

Consider a real-world example of this phenotype in action. A 40-year-old Indian man might maintain a consistent weight and a BMI of 24. While a standard global calculator calls him healthy, his waist measures 92 cm. This places him in the abdominal obesity category according to Indian guidelines. This explains why his recent blood tests might reveal elevated fasting sugar or high triglycerides despite his supposedly normal weight.

Indian cohort data made the case for these lower numbers. A Delhi cohort study of non-obese adults with a BMI under 25 found that most already carried at least one cardiovascular risk factor. That risk rose steeply within the range Western charts treat as safe. Findings like these are why researchers argued the normal ranges needed revising for Asian Indians.

The international bodies moved more cautiously. The 2004 WHO expert consultation reviewed the evidence that Asian populations face higher diabetes and heart risk at lower BMI levels. They declined to set separate Asian cutoffs and kept 25 and 30 as global classifications. Instead, they flagged 23, 27.5, 32.5, and 37.5 kg/m² as public health action points that individual countries could adopt. India took the 23 point and built its own thresholds on top of it.

Where do the 90 cm and 80 cm waist figures come from?

The waist numbers trace to Indian cohort research published in 2006. This study looked at more than 2,000 North Indian adults. It proposed 90 cm for men and 80 cm for women as an action level two. This was defined as the waist size at which cardiovascular risk factors and a BMI of 25 or more clustered together. In that founding text, they were framed as action levels where a clinician should take the risk seriously, rather than as a hard diagnostic switch.

Later Indian guidance carried the same numbers forward as abdominal obesity cutoffs. The 2025 India Obesity Commission framework lists a waist of 90 cm or more in men and 80 cm or more in women as its markers of abdominal obesity. It includes a waist-to-height ratio above 0.5 alongside these markers. It still describes waist circumference as the single best measure of abdominal obesity.

The figures reaching Indian readers today rest on Indian cohort data and current national consensus. The exact wording of the intermediate 2009 consensus statement is harder to pin down in the primary record. However, leading experts in Indian endocrinology recommend adhering strictly to the 90 and 80 cm markers for early screening and intervention.

How life stages impact your waist cutoffs

Understanding these numbers requires viewing them through the lens of different life stages, particularly for women. A single waist measurement does not tell the whole story when a body is going through significant hormonal transitions.

During reproductive years, female bodies naturally shift where fat is stored. Pregnancy requires physiological changes that temporarily alter body composition and waist measurements. In the postpartum period, it takes time for the body to establish a new metabolic baseline. Measuring waist circumference too soon after giving birth will not accurately reflect long-term metabolic risk.

Menopause introduces a more permanent shift. As estrogen levels decline, women experience a natural redistribution of body fat. Fat that was previously stored in the lower body often migrates to the abdomen. This means that a woman whose waist has stayed well below the 80 cm cutoff for decades might find that number creeping up during perimenopause and menopause. This can happen even if her overall weight remains entirely stable.

The 80 cm cutoff is an especially critical metric to monitor as women enter their late forties and fifties. This new abdominal fat is often visceral fat, which drives up cardiometabolic risk.

How to measure your waist at home

Because the cutoffs are precise, how you find your number must be precise too. If you are assessing your waist circumference at home, follow these numbered steps to get an accurate reading that you can confidently share with a clinician.

  1. Stand up straight and find the top of your hip bone and the bottom of your ribs.
  2. Place a non-stretchable measuring tape directly around your bare stomach just above the top of your hip bone.
  3. Ensure the tape is horizontal all the way around your body. Check your back in a mirror if possible to ensure it has not dipped or twisted.
  4. Do not suck in your stomach. Take a normal and relaxed breath out.
  5. Pull the tape so it is snug against your skin, but not so tight that it digs into your flesh or leaves a mark. Record the measurement.

How do you measure your waist in a clinic, and why does the number move?

How you hold the tape changes the reading, so a waist number only means something when the method is consistent. Two protocols circulate in India. International guidance places the tape midway between your lowest rib and the top of your hip bone. The Indian consensus method places it just above the top of the hip bone. Both take the reading at the end of a normal breath out while standing. They use a non-stretchable tape kept horizontal and snug without digging in.

Posture, breathing, a recent meal, and clothing all shift the figure. Two people with identical bodies can record different waists depending on tape placement. That is why the cutoffs are meaningful as consistent risk thresholds, not as a number to chase to a single decimal. The waist-to-height ratio adds a check that scales with your frame. It refines the waist reading rather than replacing the 90 and 80 cm lines.

What these cutoffs are, and what they are not

A cutoff is a population risk marker, not a personal verdict. Someone a centimetre under the line is not guaranteed safe, and someone just over it is not automatically ill. The India Obesity Commission is explicit that a waist or BMI number alone does not diagnose obesity. It treats obesity as staged. A raised BMI without organ strain or symptoms sits at Stage 1. A raised BMI plus excess waist plus real symptoms or related disease sits at Stage 2.

The tape and the scale start the conversation. Blood sugar, blood pressure, lipids, liver fat, and how you actually function finish it.

What a clinical assessment adds beyond the cutoffs

These thresholds pair naturally with a fuller assessment rather than a self-diagnosis at home. If your waist or BMI sits near an Indian cutoff, a clinician-led assessment puts the tape reading next to your labs and history. You learn what the number means for you specifically rather than what it means for the population average.

A proper clinical evaluation goes far beyond a tape measure. A doctor will typically order an HbA1c test to check your average blood sugar over the past three months. They will likely look at a fasting insulin panel to detect early insulin resistance. A comprehensive lipid profile is used to monitor triglycerides and cholesterol levels. Liver function tests and ultrasound imaging can check for non-alcoholic fatty liver disease, which is highly prevalent in South Asians with abdominal obesity. Understanding why a metabolically healthy BMI can still hide risk gives the waist number its real context.

To conclude, the key takeaway is that Indian bodies require Indian metrics. If you want to take the next step in understanding your health, you can take a specialized metabolic assessment.

This article is for general information and education only and is not medical advice, diagnosis, or treatment. GLP-1 and other medications referenced are prescription-only and are appropriate only for certain people under the supervision of a qualified clinician. Do not start, stop, or change any medication based on this article. Please consult a registered medical practitioner about your individual circumstances. Information reflects what was available at the time of review and may change.

Related articles

Premium Star Icon

Join 20 Lakh members getting healthy

Doctor-backed weight loss support you can trust

Trustpilot

Trusted by 20 Lakh +
Customers

FAQ

Dr. Saptarshi Bhattacharya

Medically reviewed by Dr. Saptarshi Bhattacharya, Chief Medical Advisor

What is GLP-1 medication?

GLP-1 is a natural hormone produced in the human body that helps regulate appetite, blood sugar, and metabolism. GLP-1 medications mimic this hormone to reduce hunger, improve insulin response, and support sustainable weight loss. Learn more

How much weight loss can I expect?

Everybody is unique, so results will vary. Clinical research on GLP-1 therapies has reported a range of outcomes; individual results vary. Your dedicated care team will personalise your plan to help you achieve sustainable progress. Learn more

What happens when I stop the medication?

Your natural appetite signals will return, which is why our programme is built for lasting independence. We prevent relapse with a two-part plan: your doctor creates a medically guided tapering schedule (not an abrupt stop), while your nutritionist helps you build sustainable habits to maintain your results long-term. Learn more

Am I eligible for GLP-1 medication?

Eligibility is a medical decision made by your Voy doctor. It is determined after a comprehensive evaluation, which includes an at-home blood test and a one-on-one consultation with a specialist endocrinologist. They will review your full health profile to see if GLP-1 therapy or another path is right for you. Learn more

Is the program safe?

When prescribed and supervised by our medical team, treatment follows clinical guidelines. Your safety is our priority, which is why every user's journey is overseen by a qualified endocrinologist to ensure care is appropriate for your health needs and to monitor your progress closely. Learn more

Still confused?

App Store
Download on theApp Store
Google Play
Get it onGoogle Play